Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35445
NL-OMON35445
Recruiting
Not Applicable

Prevalence of overactive bladder (OAB) in patients with pelvic organ prolapse (POP) and predictors of symptoms of OAB after surgical correction of POP. - OAB&POP: overactive bladder in women with prolapse before and after surgery

niversitair Medisch Centrum Sint Radboud0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsin women with genital prolapseOveractive bladder symptoms in women with pelvic organ prolapse - Frequent and strong desire to voidwith or without urinary incontinence100465901004682810029903

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
in women with genital prolapse
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
100
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • •\- Female patients, age 18 or greater, with a pelvic organ prolapse POP\-Q stage II to IV .
  • •\- Patient will undergo prolapse repair surgery.
  • •\- Patient understands the Dutch written and spoken language.

Exclusion Criteria

  • •\- Patients who currently use anticholinergic medication.
  • •\- Patients with neurological causes of OAB.
  • •\- Patients who are pregnant or wish to become pregnant.
  • •\- Patients with a history of cancer in the pelvic region, treated with radiotherapy or surgery.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Study of Overactive Bladder in Women With ProlapseUrinary Bladder, OveractivePelvic Organ Prolapse
NCT01540214Radboud University Medical Center100
Completed
Phase 3
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive BladderOveractive Bladder
NCT04917315Jeil Pharmaceutical Co., Ltd.210
Completed
Phase 2
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive BladderOveractive Bladder
NCT01868516Targacept Inc.1,635
Completed
Not Applicable
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive BladderOveractive BladderOveractive Bladder Syndrome
NCT06024005Ege University34
Terminated
Not Applicable
Overactive Bladder EducationUrinary Bladder, OveractiveUrinary Incontinence, Urge
NCT02505607Hartford Hospital22